PR Newswire

PhilWeb Elects Conglomerate Leader Lance Y. Gokongwei as Chairman to Accelerate AI Infrastructure and Transnational Ecosystem Expansion

Visa Expands Support for its Clients and the Industry as Organisations Navigate New AI Era of Cybersecurity

Koike Malaysia and Managing Director Na Chin Teong Honoured at Asia Pacific Enterprise Awards (APEA) 2026 Regional Edition for Entrepreneurial Excellence and Business Growth

A Deceased Estate Administration Expert creates an online course for Australians facing the executor role

Home Category News PR Newswire

PR Newswire

PR Newswire is the industry’s leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

GeeLark Expands Its AIGC Suite and Opens AI Content Creation to Free Users

SINGAPORE, Aug. 28, 2026 /PRNewswire/ -- GeeLark today announced a major expansion of its AIGC capabilities, introducing new AI models...

Formosa Pharmaceuticals Files Clinical Trial Application for TSY-110, an Antibody-Drug Conjugate Biosimilar Targeting HER2-Positive Breast Cancers

TSY-110 is positioned to become the first biosimilar alternative to Roche's Kadcyla® (ado-trastuzumab emtansine) in major regulated markets. TAIPEI, Aug....

Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma

SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business...

Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering

SYDNEY, Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies...

InxMed Announces Publication in The Lancet Oncology Featuring Encouraging Antitumor Activity of Ifebemtinib in Combination with Garsorasib in Previously Treated Metastatic Colorectal Cancer (CRC) Harboring KRAS G12C Mutation

NANJING, China, Aug. 28, 2026 /PRNewswire/ -- InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology company dedicated to developing innovative therapies...

Dell Technologies: From Technical Debt to Agility – Why CIOs Are Rethinking Private Cloud

SINGAPORE, Aug. 28, 2026 /PRNewswire/ -- Chris Kelly, Senior Vice President of Data Center Solutions, Asia Pacific, Japan and Greater...

Kunlun Capital-Backed InfiMaker Surpasses US$4 Million in Kickstarter Pledges, Following US$1.5 Million First‑Day Debut

BEIJING, Aug. 28, 2026 /PRNewswire/ -- InfiMaker, which received an exclusive lead investment from Kunlun Capital in its angel round...

Tigermed Announces 2026 Interim Results

HANGZHOU, China, Aug. 28, 2026 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. (300347.SZ / 3347.HK), a leading global provider of...

Warpify Robotics Secures Pre-Series A Funding for Global Expansion